Relationship between T lymphocyte subsets and cortisol in systemic lupus erythematosus

Kathmandu University Medical Journal

Volumn 7, Issue 27, 2009, Pages 213-219

  Shah, D ^a   Kiran, R ^a   Wanchu, A ^b   Bhatnagar, Archana ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

CD4+ CD8+ T cell ratio; Cortisol; Systemic lupus erythematosus; T cell activation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HYDROCORTISONE;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; INDIA; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX SCORE; T LYMPHOCYTE SUBPOPULATION;

EID: 70349678874     PISSN: 18122027     EISSN: 18122078     Source Type: Journal    
DOI: 10.3126/kumj.v7i3.2726     Document Type: Article

References (28)

1. Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology. 2002; 41:1095-1100 (Pubitemid 35203534)
2. + cells to support autoantibody synthesis. Arthritis Rhem. 1990; 33:1216-1225
3. Horowitz DA, Stohl W, Gray JD. T lymphocytes, natural killer cells, cytokines, and immune regulation. In Wallance DJ, Harn BH (editors). Dubois lupus erythematosus. Baltimore: Williams & Wilkin; 1997.p. 155-194
4. + T cell ratio and T cell activation in systemic lupus erythematosus. Scand J Rheumntol. 1999; 29: 166-170
5. Bakke AC, Kirkland PA, Kitridou RC, Quismorio FP, Rea T, Ehresmann GR. T lymphocyte subsets in systemic lupus erythematosus. Arthritis Rheum. 1983; 26:745-750
6. Smolen JS, Chused TM, Leiserson WN, Reeves JP, Alling D, Steinberg AD. Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Am J Med. 1982;72:783-790
7. McInerney MF, Clough JD, Seniztzer D, Cathcart MK. Two distinct subsets of patients with systemic lupus erythematosus. Clin Immunol Immunopathol. 1988; 49:116-132
8. + T cell in systemic lupus erythematosus: Alterations associated with prednisolone therapy. Scand J Immunol. 1990; 31:139-145
9. Zietz B, Reber T, Oertel M, Glück T, Scho lmerich J, Straub RH. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol. 2000; 27: 911-918 (Pubitemid 30389746)
10. Tan E M, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25:1271-1277 (Pubitemid 13221242)
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35: 630-640
12. Cohen PL. T and B cell abnormalities in systemic lupus. J Invest Dermatol. 1993; 100:69S-72S.
13. Kammer GM, Stein RL. T lymphocyte immune dysfunction in systemic lupus erythematosus. J Lab Clin Med. 1990; 115: 273-282 (Pubitemid 20085875)
14. Fauci A, Steinberg A, Haynes B, Whalen G. Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol. 1978; 121:1473-1479 (Pubitemid 9034477)
15. Raziuddin S, Nur MA, Alwabel AA. Selective loss of the CD 4 + inducers of suppresser T cell subsets (2H4+) in active systemic lupus erythematosus. J Rheumatol. 1989; 16:1315-1319 (Pubitemid 19276949)
16. Yang JL, Chen PZ, Dong Y, Tang FL, Zhang NZ. A preliminary study on T lymphocyte subsets in systemic lupus erythematosus. Chin Med J (Engl). 1988; 101: 665-670 (Pubitemid 19026170)
17. Lipnick RN, Balow JE, Tsokos GJ. Lymphocyte subpopulation in patient with systemic lupus erythematosus. Clin Immunol Immunopathol. 1984; 31:181-190 (Pubitemid 14138115)
18. Morimoto C, Reinherz EL, Schlossman SF, Schur PH, Mills JA, Steinberg AD. Alteration in T cell subsets in active systemic lupus erythematosus. J Clin Invest. 1980; 66:1171-1174 (Pubitemid 11233820)
19. Tsokos GC, Balow JE. Phenotypes of T lymphocytes in systemic lupus erythematosus: decreased cytotoxic/suppressor subpopulation is associated with de¢cient allogenic cytotoxic responses rather than with concanavalin A-induced suppressor cells. Clin Immunol Immunopathol. 1983; 26:262-276
20. Matsushita M, Hayashi T, Ando S, Sekigawa I, Iida N, Hashimoto H, et al. Changes of CD4/CD8 Ratio and Interleukin-16 in Systemic Lupus Erythematosus. Clin Rheumatol. 2000; 19:270-274 (Pubitemid 30612556)
21. Linker-Israeli M, Gray JD, Quismorio FP Jr, Horwitz DA. Correlation of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest. 1995; 75:762-768
22. Linker-Israeli M, Casteel N. Partial purification of systemic lupus erythematosus-derived factors that suppress production of interleukin-2. J Rheumatol. 1988; 15:952-958 (Pubitemid 18180679)
23. Hussain N, Jaffery G, Hasnain S. Serum complement C3 and C4 levels in relation to diagnosis of lupus nephritis. Trop J Pharm Res. 2008; 7: 1117-1121
24. Petri MA, Lahita RG, van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebocontrolled trial. Arthritis Rheum. 2002; 46:1820-1829 (Pubitemid 34774514)
25. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/ gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum. 2001; 44:493-507. (Pubitemid 32234605)
26. Zietz B, Reber T, Oertel M, Glück T, Schölmerich J, Straub RH. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol. 2000; 27:911-918 (Pubitemid 30389746)
27. Straub RH, Weidler C, Demmel B, Herrmann M, Kees F, Schmidt M, et al. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2004; 63:961-968 (Pubitemid 38961922)
28. Judd AM, Call GB, Barney M, McIlmoil CJ, Balls AG, Adams A, et al. Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Ann N Y Acad Sci. 2000; 917:628-637